Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
34.45
-31.36
-91.03%
Share Warrants & Outstandings
Total Reserve
68.71
53.63
15.08
28.12%
Shareholder's Funds
71.80
88.08
-16.28
-18.48%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
1.94
-1.94
-100.00%
Secured Loans
0.00
1.94
-1.94
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.11
-0.38
0.49
128.95%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.21
-0.21
-100.00%
Total Non-Current Liabilities
0.11
1.77
-1.66
-93.79%
Current Liabilities
Trade Payables
38.70
3.50
35.20
1,005.71%
Other Current Liabilities
0.94
1.32
-0.38
-28.79%
Short Term Borrowings
9.91
0.00
9.91
0.00%
Short Term Provisions
0.02
0.01
0.01
100.00%
Total Current Liabilities
49.58
4.82
44.76
928.63%
Total Liabilities
121.49
94.67
26.82
28.33%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
17.18
-0.33
-1.92%
Less: Accumulated Depreciation
6.37
5.76
0.61
10.59%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
11.41
-0.93
-8.15%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.29
-0.29
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
3.49
-0.05
-1.43%
Long Term Loans & Advances
0.75
17.47
-16.72
-95.71%
Other Non Current Assets
3.46
0.00
3.46
0.00%
Total Non-Current Assets
18.13
32.67
-14.54
-44.51%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
23.99
14.02
58.44%
Sundry Debtors
56.54
16.22
40.32
248.58%
Cash and Bank
0.16
6.83
-6.67
-97.66%
Other Current Assets
0.17
2.02
-1.85
-91.58%
Short Term Loans and Advances
8.13
12.95
-4.82
-37.22%
Total Current Assets
103.36
62.00
41.36
66.71%
Net Current Assets (Including Current Investments)
53.78
57.18
-3.40
-5.95%
Total Current Assets Excluding Current Investments
103.00
62.00
41.00
66.13%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
94.67
26.82
28.33%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
1.94
7.97
410.82%
Book Value per share (adjusted)
232.39
5.11
227.28
4,447.75%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






